SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-092031
Filing Date
2024-04-10
Accepted
2024-04-10 17:10:31
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d782923ds3.htm S-3 408018
2 EX-4.2 d782923dex42.htm EX-4.2 257621
3 EX-5.1 d782923dex51.htm EX-5.1 32699
4 EX-23.1 d782923dex231.htm EX-23.1 2022
5 EX-FILING FEES d782923dexfilingfees.htm EX-FILING FEES 55184
6 GRAPHIC g782923g0405074940158.jpg GRAPHIC 4483
7 GRAPHIC g782923g0405074940576.jpg GRAPHIC 1799
8 GRAPHIC g782923g0405074940879.jpg GRAPHIC 3447
9 GRAPHIC g782923g0410073142046.jpg GRAPHIC 2194
  Complete submission text file 0001193125-24-092031.txt   773738
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-278612 | Film No.: 24836548
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)